Area of research
Pathology and Forensic Medicine · Genetics
Research interest
Research interests include Medicine, Lymphoma, Hodgkin lymphoma, Fludarabine, Hazard ratio, and Chimeric antigen receptor.
Clinical presentation, management, and outcome of TIAN in CNS lymphoma treated with CD19-CAR T-cell therapy
Five-year follow-up of a phase 2 study of ibrutinib plus fludarabine, cyclophosphamide, and rituximab as initial therapy in CLL
Toxicities and outcome after <scp>CD19</scp>‐directed chimeric antigen receptor T‐cell therapy for secondary neurolymphomatosis
Neurotoxicity and management of primary and secondary central nervous system lymphoma after adoptive immunotherapy with CD19-directed chimeric antigen receptor T-cells
NCCN Guidelines® Insights: Hodgkin Lymphoma, Version 2.2022
Hodgkin Lymphoma, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology
Fatal neurotoxicity after chimeric antigen receptor T-cell therapy: An unexpected case of fludarabine-associated progressive leukoencephalopathy
Clinical presentation, management, and biomarkers of neurotoxicity after adoptive immunotherapy with CAR T cells
Ibrutinib plus fludarabine, cyclophosphamide, and rituximab as initial treatment for younger patients with chronic lymphocytic leukaemia: a single-arm, multicentre, phase 2 trial
Potentially Avoidable Hospital Readmissions in Patients With Advanced Cancer
NCCN Guidelines Insights: Hodgkin Lymphoma, Version 1.2018
Symptoms of posttraumatic stress disorder among hospitalized patients with cancer
Use of Antidepressant Medications Moderates the Relationship Between Depressive Symptoms and Hospital Length of Stay in Patients with Advanced Cancer
The relationship between physical and psychological symptoms and health care utilization in hospitalized patients with advanced cancer
Hodgkin Lymphoma Version 1.2017, NCCN Clinical Practice Guidelines in Oncology
A B Cell Regulome Links Notch to Downstream Oncogenic Pathways in Small B Cell Lymphomas
Pediatric-type nodal follicular lymphoma: a biologically distinct lymphoma with frequent MAPK pathway mutations
Hybrid FDG-PET/MR compared to FDG-PET/CT in adult lymphoma patients
Subgraph augmented non-negative tensor factorization (SANTF) for modeling clinical narrative text
Hodgkin Lymphoma, Version 2.2015
Automatic lymphoma classification with sentence subgraph mining from pathology reports
Hodgkin Lymphoma, Version 2.2012 Featured Updates to the NCCN Guidelines